Glenmark Pharmaceuticals consolidated net profit declines 10.56% in the December 2021 quarter

Sales rise 13.87% to Rs 3141.47 crore

Net profit of Glenmark Pharmaceuticals declined 10.56% to Rs 221.90 crore in the quarter ended December 2021 as against Rs 248.10 crore during the previous quarter ended December 2020. Sales rose 13.87% to Rs 3141.47 crore in the quarter ended December 2021 as against Rs 2758.74 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales3141.472758.74 14 OPM %22.0619.21 -PBDT640.35449.75 42 PBT521.42334.55 56 NP221.90248.10 -11

Powered by Capital Market - Live News